| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 07/08/2004 | US20040132766 1H-imidazo dimers |
| 07/08/2004 | US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 07/08/2004 | US20040132750 Acyl guanidine compounds and use thereof |
| 07/08/2004 | US20040132747 Novel heteroaryl derivatives and their use as medicaments |
| 07/08/2004 | US20040132740 structurally related to compounds such as ciprofloxacin but without the carboxylic acid or ester functionality, are not only also highly effective as antibiotics, but show a superior antibacterial effect. |
| 07/08/2004 | US20040132727 Quinoline and quinazoline derivatives and drugs containing the same |
| 07/08/2004 | US20040132724 e.g., cis-1-Acetyl-6-ethyl-N-(4-ethylphenyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinamine; atopic dermatitis, urticaria, various allergies bullous pemphigoid, industrial sensitization, chronic transplant rejection and COPD |
| 07/08/2004 | US20040132722 Glycoprotein-mediated MDR |
| 07/08/2004 | US20040132618 Therapeutic amides |
| 07/08/2004 | CA2510846A1 New carboxylic acid amides,the preparation thereof and their use as pharmaceutical compositions |
| 07/08/2004 | CA2509645A1 Antibiotics containing borinic acid complexes and methods of use |
| 07/08/2004 | CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/07/2004 | EP1435356A1 Quinoline derivatives as CRTH2 antagonists |
| 07/07/2004 | EP1434813A2 Polymers and oligomers, their synthesis, and electronic devices incorporating same |
| 07/07/2004 | EP1434585A1 Alkyne matrix metalloproteinase inhibitors |
| 07/07/2004 | EP1434581A1 3- hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors |
| 07/07/2004 | EP1317520A4 Lubricating compositions containing aromatized 1,2-dihydro-2,2,4-trimethylquinoline polymers |
| 07/07/2004 | CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives |
| 07/07/2004 | CN1511035A Gatifloxacin pentahydrate |
| 07/07/2004 | CN1156451C Betz 2-adrenoceptor agonists |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759428 Indole nitriles |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/01/2004 | WO2004055015A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | WO2004054583A1 Crystalline forms of gatifloxacin and processes for preparation |
| 07/01/2004 | WO2003080577A3 Amidoacetonitrile compounds |
| 07/01/2004 | WO2003045878A8 2,w-diaminocarboxylic acid compounds |
| 07/01/2004 | US20040127710 Red luminescent compound and organic electroluminescent device using the same |
| 07/01/2004 | US20040127708 antiviral activities; aids treatment |
| 07/01/2004 | US20040127495 Preferential suppressors of immunoglobulins, used as immunosuppressants and antiallergens |
| 07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
| 07/01/2004 | US20040127487 For therapy and prophylaxis of bone diseases, cancer, systemic granuloma, immunological diseases, allergy, atopy, asthma, gumboil, gingivitis, periodontitis, neurocyte death, Alzheimer's diseases, lungs injury, pulmopathy, acute hepatitis |
| 07/01/2004 | DE10260879A1 Mittel zum Färben von keratinhaltigen Fasern Formulations for coloring keratin-containing fibers |
| 07/01/2004 | DE10259407A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis |
| 07/01/2004 | CA2510625A1 Crystalline forms of gatifloxacin and processes for preparation |
| 07/01/2004 | CA2509244A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 06/30/2004 | EP1433785A1 Agents for the coloration of keratinous fibres |
| 06/30/2004 | EP1433779A1 Use of nitriles as inhibitors of non-proteolytic enzymes |
| 06/30/2004 | EP1433778A1 Use of nitriles as rotamase inhibitors |
| 06/30/2004 | EP1433468A1 N-Methyl quinolinium imines used for dyeing keratin containing fibres |
| 06/30/2004 | EP1432701A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 06/30/2004 | EP1432678A1 Hiv protease inhibitors |
| 06/30/2004 | EP1432421A1 Quinoline derivatives as neuropeptide y antagonists |
| 06/30/2004 | EP1432394A1 Agent for coloring keratin fibers |
| 06/30/2004 | CN1509290A Process for synthesis of derivatives of 2,30dihydro-1,4-dioxino-[2,3-f]quinoline |
| 06/30/2004 | CN1509175A Novel Use |
| 06/30/2004 | CN1509140A Pyridinyl fused bicyclic amide as fungicides |
| 06/30/2004 | CN1155558C N-alkoxyalkyl-N, N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |
| 06/24/2004 | WO2004052919A2 Peptide deformylase inhibitors |
| 06/24/2004 | WO2004052872A1 Haloalkene compounds, process for their production and pesticides containing them |
| 06/24/2004 | WO2004052366A1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | WO2002092594A8 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 06/24/2004 | US20040122181 Vulcanization accelerators |
| 06/24/2004 | US20040121998 CRF antagonistic quino- and quinazolines |
| 06/24/2004 | US20040121947 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 06/23/2004 | EP1431289A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 06/23/2004 | EP1431288A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |
| 06/23/2004 | EP1430030A1 N-type calcium channel antagonists for the treatment of pain |
| 06/23/2004 | EP1430029A1 N-type calcium channel antagonists for the treatment of pain |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/23/2004 | EP1246817B1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 06/23/2004 | CN1507436A Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/22/2004 | US6753429 1,4-disubstituted benzenes as insecticides |
| 06/22/2004 | US6753334 Preparing a phenyl or quinolinyl hydrazine by reducing the corresponding diazonium salt with ascorbic acid and heating; colorless product; intermediates to drugs for reducing tissue damage from ischemia or hypoxia |
| 06/22/2004 | US6753333 Arginine salt forms of s-(-)-9- fluoro-6,7-dihydro 8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo(i,j)quinolizine-2 -carboxylic acid, a process for their preparation and pharmaceutical formulations which are |
| 06/17/2004 | WO2004050657A2 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| 06/17/2004 | WO2004050627A1 A quinoline amide derivative as agent against disorders of the cns |
| 06/17/2004 | WO2004050626A1 A quinoline amide derivative as agent against disorders of the cns |
| 06/17/2004 | WO2004050623A1 Methods for preparing phenylalkyne derivatives |
| 06/17/2004 | WO2004050609A1 Substituted ureas and carbamates |
| 06/17/2004 | WO2004037796A3 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 06/17/2004 | WO2004018414A3 Antibacterial agents |
| 06/17/2004 | WO2003106421A3 Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity |
| 06/17/2004 | US20040116696 Using fluorine substituted 2-phenylpyridine, phenylpyrimidine or phenylquinoline compound |
| 06/17/2004 | US20040116694 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 06/17/2004 | US20040116468 Therapeutic agent for glomerular disease |
| 06/17/2004 | US20040116455 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/17/2004 | US20040116405 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | US20040113124 Addition polymer |
| 06/17/2004 | DE10256405A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
| 06/17/2004 | DE10247233A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
| 06/17/2004 | CA2507875A1 Methods for preparing phenylalkyne derivatives |
| 06/17/2004 | CA2507484A1 Substituted ureas and carbamates |
| 06/17/2004 | CA2506741A1 Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 06/16/2004 | WO2004054978A1 Quinoline derivative as diagnostic probe for disease with tau protein accumulation |
| 06/16/2004 | EP1428820A1 Non-imidazole alkylamines as histamine H-3-receptor ligands and their therapeutic applications |
| 06/16/2004 | EP1428531A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 06/16/2004 | EP1427701A1 3-amino carbonyl-substituted benzoylcyclohexanediones that can be used as herbicides |
| 06/16/2004 | EP1427408A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE) |
| 06/16/2004 | EP1089963B1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 06/16/2004 | EP0983243B1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
| 06/16/2004 | EP0807105B1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists |
| 06/16/2004 | CN1505609A Compound useful as intermediates for cholesteryl ester transfer protein (CETP) inhibitors |
| 06/16/2004 | CN1505607A Peptide-deformylase inhibitors |
| 06/16/2004 | CN1504461A Preparing method for 1H-quinoline-2-ketone compound |